NDC 69539-074 – Deferasirox
Deferasirox 180 mg/1 · Tablet · Oral
Product NDC69539-074
Product details
- Brand name
- Deferasirox
- Generic name
- Deferasirox
- Labeler
- MSN LABORATORIES PRIVATE LIMITED
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA210945
- Marketed since
- June 16, 2020
- Listing expires
- December 31, 2026
- Pharmacologic class
- Iron Chelator
Active ingredients
- Deferasirox 180 mg/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 69539-074-30 | 30 TABLET in 1 BOTTLE (69539-074-30) | Jun 16, 2020 |
| 69539-074-99 | 1000 TABLET in 1 BOTTLE (69539-074-99) | Jun 16, 2020 |
Other Deferasirox products
- 73190-052 Deferasirox 360 mg/1 · Tablet · AvKARE
- 43598-851 Deferasirox 360 mg/1 · Tablet · Dr. Reddy's Laboratories Inc
- 43598-852 Deferasirox 180 mg/1 · Tablet · Dr. Reddy's Laboratories Inc
- 43598-853 Deferasirox 90 mg/1 · Tablet · Dr. Reddy's Laboratories Inc
- 69539-073 Deferasirox 90 mg/1 · Tablet · MSN LABORATORIES PRIVATE LIMITED
- 69539-075 Deferasirox 360 mg/1 · Tablet · MSN LABORATORIES PRIVATE LIMITED
- 70700-271 Deferasirox 360 mg/1 · Tablet · Xiromed, LLC
- 70700-270 Deferasirox 180 mg/1 · Tablet · Xiromed, LLC
- 70700-269 Deferasirox 90 mg/1 · Tablet · Xiromed, LLC
- 45963-455 Deferasirox 250 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 45963-456 Deferasirox 500 mg/1 · Tablet, For Suspension · Actavis Pharma, Inc.
- 62332-412 Deferasirox 360 mg/1 · Tablet, Film Coated · Alembic Pharmaceuticals Inc.